{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:03:48Z","timestamp":1790395428792,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS060722"],"award-info":[{"award-number":["NS060722"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS082151"],"award-info":[{"award-number":["NS082151"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hershey Medical Center Clinical Research Center"},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["RR033184"],"award-info":[{"award-number":["RR033184"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TR000127"],"award-info":[{"award-number":["TR000127"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Center for Advancing Translational Sciences","award":["TR002016"],"award-info":[{"award-number":["TR002016"]}]},{"name":"PA Department of Health Tobacco CURE Funds"},{"name":"Translational Brain Research Center"},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000319","name":"Alzheimer's Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012479","name":"Weston Brain Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.neurobiolaging.2019.01.004","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T11:36:49Z","timestamp":1547638609000},"page":"194-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Multimodal MRI evaluation of parkinsonian limbic pathologies"],"prefix":"10.1016","volume":"76","author":[{"given":"Ernest W.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mechelle M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol","family":"De Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangam","family":"Kanekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hipo.22183","article-title":"Hippocampus and striatum: dynamics and interaction during acquisition and sleep-related motor sequence memory consolidation","volume":"23","author":"Albouy","year":"2013","journal-title":"Hippocampus"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mds.25887","article-title":"Neuropathological features of multiple system atrophy with cognitive impairment","volume":"29","author":"Asi","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1146\/annurev-clinpsy-032813-153705","article-title":"Impulsive and compulsive behaviors in Parkinson's disease","volume":"10","author":"Averbeck","year":"2014","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/mds.26471","article-title":"Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease","volume":"31","author":"Barbagallo","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrn875","article-title":"The amygdala and reward","volume":"3","author":"Baxter","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib6","first-page":"141","article-title":"Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia","volume":"42","author":"Bertrand","year":"2004","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mds.10444","article-title":"Parkinson's disease is associated with hippocampal atrophy","volume":"18","author":"Camicioli","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib8","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1212\/WNL.0b013e318259e1c5","article-title":"Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study","volume":"78","author":"Carlesimo","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/mds.25904","article-title":"Apathy in Parkinson's disease is associated with nucleus accumbens atrophy: a magnetic resonance imaging shape analysis","volume":"29","author":"Carriere","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib10","doi-asserted-by":"crossref","DOI":"10.1080\/23311908.2015.1131476","article-title":"Neuropsychiatric symptoms and their impact on quality of life in multiple system atrophy","volume":"3","author":"Ceponiene","year":"2016","journal-title":"Cogent Psychol."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e318284070c","article-title":"Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis","volume":"80","author":"Cochrane","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib12","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/brain\/awv114","article-title":"Expanding the spectrum of neuronal pathology in multiple system atrophy","volume":"138","author":"Cykowski","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/mds.27318","article-title":"Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients","volume":"33","author":"Du","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/mds.26417","article-title":"Quantitative susceptibility mapping of the midbrain in Parkinson's disease","volume":"31","author":"Du","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/mds.21198","article-title":"Movement disorder society-sponsored revision of the unified Parkinson's disease rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan","volume":"22","author":"Goetz","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.expneurol.2011.09.035","article-title":"Stress, depression and Parkinson's disease","volume":"233","author":"Hemmerle","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0165-0173(99)00023-5","article-title":"The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking","volume":"31","author":"Ikemoto","year":"1999","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000121388","article-title":"Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy","volume":"5","author":"Jellinger","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00702-012-0771-5","article-title":"Mild cognitive impairment in Parkinson disease: heterogenous mechanisms","volume":"120","author":"Jellinger","year":"2013","journal-title":"J.\u00a0Neural. Transm. (vienna)"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/mds.20371","article-title":"Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia","volume":"20","author":"Junque","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.parkreldis.2008.05.007","article-title":"Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease","volume":"15","author":"Kalaitzakis","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000444021","article-title":"Age, gender, comorbidity, and the MDS-UPDRS: results from a population-based study","volume":"46","author":"Keezer","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF01271246","article-title":"The motor performance test series in Parkinson's disease is influenced by depression","volume":"103","author":"Kuhn","year":"1996","journal-title":"J.\u00a0Neural. Transm. (vienna)"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib26","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/mds.27381","article-title":"Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes","volume":"33","author":"Lewis","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archneur.1989.00520430059018","article-title":"Memory impairment in patients with progressive supranuclear palsy","volume":"46","author":"Litvan","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mrm.24272","article-title":"Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping","volume":"69","author":"Liu","year":"2013","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1109\/TMI.2011.2182523","article-title":"Accuracy of the morphology enabled dipole inversion (MEDI) algorithm for quantitative susceptibility mapping in MRI","volume":"31","author":"Liu","year":"2012","journal-title":"IEEE Trans. Med. Imag."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2012.12.008","article-title":"Volumetric parcellation methodology of the human hypothalamus in neuroimaging: normative data and sex differences","volume":"69","author":"Makris","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib32","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1212\/CON.0000000000000348","article-title":"Diagnostic approach to atypical parkinsonian syndromes","volume":"22","author":"McFarland","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib33","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mds.22902","article-title":"Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy","volume":"25","author":"O'Sullivan","year":"2010","journal-title":"Mov. Disord."},{"issue":"Pt 2","key":"10.1016\/j.neurobiolaging.2019.01.004_bib34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/brain\/117.2.235","article-title":"The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology","volume":"117","author":"Papp","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s004010000292","article-title":"Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration","volume":"101","author":"Piao","year":"2001","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib36","first-page":"1850","article-title":"Neuroimaging evidence of gray and white matter damage and clinical correlates in progressive supranuclear palsy","volume":"262","author":"Piattella","year":"2015","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2011.08.039","article-title":"Anxiety in Parkinson's disease: a critical review of experimental and clinical studies","volume":"62","author":"Prediger","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1756285613511507","article-title":"A\u00a0review of the use of magnetic resonance imaging in Parkinson's disease","volume":"7","author":"Pyatigorskaya","year":"2014","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib39","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopsych.2010.04.027","article-title":"Amygdala activity, fear, and anxiety: modulation by stress","volume":"67","author":"Ressler","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib40","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.nicl.2018.05.027","article-title":"Parkinson's disease related signal change in the nigrosomes 1-5 and the substantia nigra using T2* weighted 7T MRI","volume":"19","author":"Schwarz","year":"2018","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0022-510X(79)90073-X","article-title":"Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases","volume":"43","author":"Spokes","year":"1979","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature10194","article-title":"Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking","volume":"475","author":"Stuber","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fneur.2017.00139","article-title":"Striatal and hippocampal atrophy in idiopathic Parkinson's disease patients without dementia: a morphometric analysis","volume":"8","author":"Tanner","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib44","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1440-1789.2003.00543.x","article-title":"Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration","volume":"24","author":"Wakabayashi","year":"2004","journal-title":"Neuropathology"},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/pmj.77.904.89","article-title":"Parkinson's disease and anxiety","volume":"77","author":"Walsh","year":"2001","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/mrm.25358","article-title":"Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker","volume":"73","author":"Wang","year":"2014","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40035-016-0064-2","article-title":"Utility of susceptibility-weighted imaging in Parkinson's disease and atypical Parkinsonian disorders","volume":"5","author":"Wang","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib50","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/mds.24023","article-title":"Questionnaire for impulsive-compulsive disorders in Parkinson's disease-rating scale","volume":"27","author":"Weintraub","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00429-014-0907-5","article-title":"Multimodal MRI of the hippocampus in Parkinson's disease with visual hallucinations","volume":"221","author":"Yao","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-010-0702-1","article-title":"Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy","volume":"120","author":"Yokota","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2019.01.004_bib53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.parkreldis.2016.12.007","article-title":"Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes","volume":"35","author":"Zhang","year":"2017","journal-title":"Park. Relat. Disord."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019300144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019300144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:28:02Z","timestamp":1759318082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458019300144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":53,"alternative-id":["S0197458019300144"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.01.004","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal MRI evaluation of parkinsonian limbic pathologies","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}